所有版本 - 学术资源搜索

Renal outcomes in medically and surgically treated primary aldosteronism

GL Hundemer, GC Curhan, N Yozamp, M Wang… - …, 2018 - Am Heart Assoc

Lifelong therapy with mineralocorticoid receptor antagonists (MRAs) or surgical
adrenalectomy are the recommended treatments for primary aldosteronism (PA). Whether …

被引用次数：173 相关文章

Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism

GL Hundemer, GC Curhan, N Yozamp, M Wang… - Hypertension, 2018 - cir.nii.ac.jp

抄録< jats: p> Lifelong therapy with mineralocorticoid receptor antagonists (MRAs) or
surgical adrenalectomy are the recommended treatments for primary aldosteronism (PA) …

[HTML] nih.gov

[HTML][HTML] RENAL OUTCOMES IN MEDICALLY AND SURGICALLY TREATED PRIMARY ALDOSTERONISM

GL Hundemer, GC Curhan, N Yozamp… - … (Dallas, Tex.: 1979), 2018 - ncbi.nlm.nih.gov

Lifelong therapy with mineralocorticoid receptor antagonists (MRAs) or surgical
adrenalectomy are the recommended treatments for primary aldosteronism (PA). Whether …

高级搜索

QQ 群

Renal outcomes in medically and surgically treated primary aldosteronism

Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism

[HTML][HTML] RENAL OUTCOMES IN MEDICALLY AND SURGICALLY TREATED PRIMARY ALDOSTERONISM

Primary Aldosteronism

Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.

Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism

Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.

引用